Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Mayo Clinic
Maria Sklodowska-Curie National Research Institute of Oncology
SOLTI Breast Cancer Research Group
Novartis
Infinity Pharmaceuticals, Inc.
Hoffmann-La Roche
Jules Bordet Institute
Duke University
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
Stanford University
Emory University
Novartis
Hadassah Medical Organization
St. Luke's-Roosevelt Hospital Center
GE Healthcare
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer